Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Teva UK launches new generic ophthalmic solution

Teva UK launches new generic ophthalmic solution

6th October 2010

Teva UK has announced the launch of a new generic ophthalmic solution, which is designed for the treatment of glaucoma.

Dorzolamide/Timolol is based on the branded product Cosopt from Merck Sharpe and Dohme and is indicated for use against elevated intraocular pressure among sufferers of open-angle or pseudo-exfoliative glaucoma.

The 20mg/5mg per ml treatment has been designed for patients who have proven unresponsive to topical beta-blocker monotherapy and is branded with the Teva 360 livery, denoting its safety performance.

Kim Innes, commercial director at Teva UK, said: "We are pleased to add this product to our ever-expanding product portfolio – the widest of any UK generics supplier."

Teva UK is currently planning to widen its drug offering even further via the introduction of a new range of over-the-counter treatments in autumn 2010.

More than 20 different product lines are to be introduced, including cold and flu relief medication and gastrointestinal therapies.ADNFCR-8000103-ID-800101998-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.